Smith & Nephew
LONDON, October 19, 2011 -
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, today announced the appointment of Stphane Thiroloix to the position of President, Europe Advanced Surgical Devices Division (ASD).
HULL, England, August 8, 2011 -
The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN; NYSE: SNN), updates today on its Negative Pressure Wound Therapy (NPWT) position in the European market, including the status of recent legal, regulatory and research developments.
HULL, England, May 25, 2011 -
- With Photo
The Advanced Wound Management division of Smith & Nephew, (LSE: SN; NYSE:
SNN) today announced the CE Mark approval for PICO(TM), an effective,
single-use, Negative Pressure Wound Therapy (NPWT) system for acute and
chronic wounds, high-risk surgical incisions and skin grafts.
YORK, England, December 16, 2010 - The National Institute for Health and Clinical Excellence
(NICE) has advised healthcare professionals in the UK that the use of low
intensity pulsed ultrasound (LIPUS) technology represents a safe and
effective treatment option to reduce the healing time in patients with bone
fractures(1).
MEMPHIS, Tennessee, December 2, 2010 - A newly released patient registry reports that hip replacement implants
made from ceramicized metal heads which articulate against polyethylene lined
cups have been shown to have superior survivorship compared to implants made
from any other material five years after surgery.
More News
- DUROLANE(R) Granted Major EU License Extension for the Treatment of Human Joints
- Smith and Nephew Remains Committed to NPWT Market; will Continue to Serve Patients in United Kingdom
- /C O R R E C T I O N — Smith & Nephew/
- 80-percent of US surgeons choose the BHR hip as it outperforms all other metal-on-metal resurfacing devices
- Smith & Nephew Takes Single Injection PMA to Next Stage
- UK Court of Appeal Rules in Smith & Nephew’s Favour
